newsfilter
← Latest News
Business Wire·

Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders

Company Calls Out Misrepresentations from Investor Group Sesen Bio, Inc. (NASDAQ:SESN) today issued the following statement reiterating the Company's confidence in, and commitment to, the pending merger with Carisma